to experience the full functionality of mail.com.
Enhanced by Google
January 28, 2016
Amgen trounces Street views with 39 pct. jump in 4Q profit
Capping an enviable year, Amgen's fourth-quarter profit soared 39 percent, as the biologic drugmaker posted higher revenue ...
December 04, 2015
FDA OKs first generic for Gleevec leukemia pill
U.S. regulators have approved the first generic version of one of the first very effective — and expensive — cancer drugs, ...
November 22, 2015
Report: Pfizer, Allergan close to $150 billion merger deal
Pfizer Inc. and Allergan PLC are on the cusp of reaching a $150 billion deal that would create the world's largest drugmaker ...
November 20, 2015
FDA approves Takeda drug for blood cancer multiple myeloma
The U.S. Food and Drug Administration on Friday approved a third drug to treat multiple myeloma, a type of blood cancer.